Latest in Cell & Gene Therapy

Alithea Genomics launches extraction-free, RNA-seq for 3D drug screening and toxicology

The streamlined, one-day workflow delivers full transcriptome coverage in a massively multiplexed manner, making the method ideal for large-scale mechanistic and toxicity studies in 3D models

Find out more

Pharma leaders must separate AI hype from actionable opportunity, warns NIRAS

A new report from the company urges pharmaceutical executives to approach AI adoption with trust, transparency and traceability, outlining how the technology can drive...
See more

Bristol Myers Squibb strengthens and diversifies cell therapy portfolio with acquisition of Orbital Therapeutics

Bristol Myers Squibb will acquire Orbital Therapeutics in a $1.5bn deal, adding next-generation RNA-based in vivo CAR T technology to its cell therapy pipeline and expanding treatment potential in autoimmune diseases

Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology

Algen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery

CTMC and Einstein Hospital Israelita form global alliance to expand access to cell therapy

The new CTMC Network Alliance will accelerate the adoption of cell and gene therapies across Latin America, aiming to make life-saving treatments more accessible through shared expertise, training and manufacturing innovation

New CGT centre in Bangkok to boost Southeast Asia’s biotech ecosystem

eXmoor Pharma and Siam Bioscience form a strategic partnership to establish leading cell and gene therapy services in Southeast Asia

Huntington's breakthrough: gene therapy appears to slow progression of disease by 75%

uniQure has announced positive topline results from a Phase I/II clinical trial of a new Huntington's disease treatment, spurring hopes that more people at risk will undergo testing

ScaleReady awards nearly $2m in G-Rex grants to advance cell and gene therapy manufacturing in California

The initiative supports leading academic GMP facilities in developing scalable, cost-effective platforms for CAR-T and other cell therapies, reinforcing California’s position as a global hub for CGT innovation

Mana.bio launches pioneering large language model-powered AI agent for lipid nanoparticles

Described as a "ChatGPT for LNPs", LLM Mina will be publicly available at no cost

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced

Latest posts in Cell & Gene Therapy

ProBioGen chosen to lead GMP manufacturing operations at Berlin Center for Gene and Cell Therapies

The company will oversee the design, lead the construction and subsequently operate the 4600-square-meter GMP manufacturing unit

Sapio Sciences and Ultima Genomics to work together in advancing multiomics research

The partnership delivers global, end-to-end solutions aimed at making genomics research more streamlined and accessible

Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development

Collaboration will accelerate stable cell line development in AAV genomic medicine development and ultimately also shorten the development timeline to clinic

Cellbricks Therapeutics reaches key milestone using Rousselot biomaterials

Rousselot and Cellbricks Therapeutics have achieved promising preclinical results using medical-grade biomaterials to advance 3D-bioprinted tissue integration in regenerative medicine

Unlocking the potential of the non-coding genome for precision medicine

The non-coding genome, once dismissed as "junk DNA," is now recognised as a fundamental regulator of gene expression and a key player in understanding complex diseases

Responding to cell & gene fill-finish and automation scale-up challenges

These therapies are not just scientific marvels - they're changing lives

SPT Labtech and Cavendish combine technologies to improve the cell-based assay design process

By combining technologies, the companies hope to optimise the cell assay development workflow with automation

Univercells and Repligen join forces to optimise the real-time monitoring of biologic production

By performing real-time monitoring in bioreactors, the companies will eliminate the need for manual nutrient testing when growing cell cultures

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases

Terumo's Quantum Platform integrates CAR-T production, protocol states

The quantum platform unifies T cell activation, lentiviral vector transduction and CAR-T expansion to streamline the manufacturing process

New US Pharmacopeia draft chapter recognises mass photometry for gene therapy quality control

The technique, alongside SEC-MALS, AUC, UV-vis, CD-MS and TEM can assist gene therapy manufacturers in accurately determining the quality of their AAV capsids

Sponsor content

PromoCell launches GMP cell culture media services for cell therapy

New offering to debut at 32nd ESGCT Congress, October 7–10 in Seville, Spain

The basics of cell culture

Key steps in manufacturing cell therapies

A smarter alternative to pipette-filling cryovials

By switching to an automated cryovial filling solution, such as award-winning cryoFIL, manufacturers remove one of the most error-prone, resource-heavy steps from their...

The challenges and trends in gene therapy

Three perspectives on the challenges and trends in gene therapy

Andelyn Biosciences adds Stanton Lab CNS Capsids to AAV Curator Platform

Andelyn Biosciences expands AAV Curator® Platform offering to include Stanton Lab CNS Capsids through a license agreement from the Broad Institute of MIT and Harvard

Ensuring cGMP compliance in cell and gene therapy manufacturing

By adhering to GMP principles, manufacturers can mitigate risks, streamline processes, and ensure that their products meet the highest standards of safety and efficacy

Andelyn Biosciences produces viral vector for Nationwide Children’s Hospital using AAV Curator Platform

Andelyn Biosciences AAV Curator® Platform used to manufacture clinical grade viral vector for FDA-Authorised first-in-world Universal Donor CRISPR/AAV Transduced CAR-NK...

Andelyn applies AAV Curator to treat ultra-rare NEDAMSS patient

Andelyn Biosciences applies the AAV Curator platform to deliver novel gene therapy for an ultra-rare NEDAMSS disease patient 14-months after diagnosis

AnalytiChem debuts branded Redipor culture media

The branded culture media line combines the expertise of BioTrading, Redipor by Cherwell and NEL to provide customers with tailored batch sizes, formulations and packaging...

Merck launches single-use reactor designed to accelerate antibody drug conjugate manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing. It increases efficiency by 70% compared to stainless steel or glass manufacturing methods and...

Cell culture bags - Understanding the basics

Uncover the benefits of cell culture bags and why they could be the ideal solution for your cell processing application.

Symbiosis Pharmaceutical Services shares the industry events it will attend in 2024

The aseptic manufacturing specialists will have an exhibiting presence at an additional 5 events globally this year

Featured companies

CPTx is pioneering in vivo production of precision genetic medicines using single-stranded DNA.
See more